本页面由Tiger Trade Technology Pte. Ltd.提供服务

Therapeutics

3.61
-0.0350-0.96%
盘后:3.680.0700+1.94%16:18 EDT
成交量:60.33万
成交额:220.06万
市值:1.13亿
市盈率:-0.87
高:3.71
开:3.64
低:3.60
收:3.65
52周最高:46.75
52周最低:3.35
股本:3,129.00万
流通股本:1,839.33万
量比:0.83
换手率:3.28%
股息:- -
股息率:- -
每股收益(TTM):-4.1300
每股收益(LYR):-2.8503
净资产收益率:-59.21%
总资产收益率:-37.36%
市净率:0.52
市盈率(LYR):-1.27

数据加载中...

2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/14

重要事件披露

Form 8-K - Current report
2024/08/12

重要事件披露

Form 8-K - Current report
2024/07/29

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/15

重要事件披露

Form 8-K - Current report
2024/05/21

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/09

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/08

SEC问询函

Form CORRESP - Correspondence
2024/04/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/04/03

重要事件披露

Form 8-K - Current report
2024/03/29

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/03/28

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/28

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/03/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/25

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/25

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/22

重要事件披露

Form 8-K - Current report